ArticleGynecologic oncology reports2026
Vaginal mucosal melanoma recurrence with intracardiac metastasis treated with immunotherapy.
Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vaginal mucosal melanoma (VMM) is highly malignant tumour with limited cases reported worldwide. There are no guidelines in place to inform best therapy; instead, management is guided by previous studies and outcomes. There have been no reported cases of vaginal mucosal melanoma metastasizing to the heart. Case Presentation: This case follows 54-year-old, otherwise well woman with VMM metastasizing to the heart. It outlines diagnosis, multi-specialty input, chosen treatments and progress of recovery and successful disease control. Conclusion: Primary surgical resection and adjuvant immunotherapy were best indicated and depicted best survival outcomes for this case. Multidisciplinary expert care is essential in clinical decision making. Immunotherapy significant improved survival, and side effects were able to be managed with good response.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.